Viewing Study NCT00201487



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00201487
Status: WITHDRAWN
Last Update Posted: 2013-10-31
First Post: 2005-09-16

Brief Title: Choline Quantification in Breast Cancer by MRS
Sponsor: Norwegian University of Science and Technology
Organization: Norwegian University of Science and Technology

Study Overview

Official Title: Choline Quantification in Breast Cancer by MRS
Status: WITHDRAWN
Status Verified Date: 2013-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: We chose to use an exsisting NMR pulse sequence already established and available at the hospital
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Choline has been found in increased concentration in breast cancer patients Hypothesis The choline signal as observed by MRS is sensitive to treatment and a positive response to treatment will give a reduction in choline concentration

The purpose of this study is to establish methods for quantification of choline in breast cancer by MRS
Detailed Description: 1 Establishment of new MRS sequence for choline quantification of choline This sequence is choline-selective and signals from water and lipids are suppressed simultaneously
2 Compare to different methods for choline quantification The first method is quantification through an external phantom standard containing a known concentration of choline The other method is based on the utilisation of internal water signal as a reference

Both calculations can be performed from the same MR exam Ten patients will be included in the study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None